These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19413351)

  • 41. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability.
    Corada M; Liao F; Lindgren M; Lampugnani MG; Breviario F; Frank R; Muller WA; Hicklin DJ; Bohlen P; Dejana E
    Blood; 2001 Mar; 97(6):1679-84. PubMed ID: 11238107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VE-cadherin is a critical endothelial regulator of TGF-beta signalling.
    Rudini N; Felici A; Giampietro C; Lampugnani M; Corada M; Swirsding K; Garrè M; Liebner S; Letarte M; ten Dijke P; Dejana E
    EMBO J; 2008 Apr; 27(7):993-1004. PubMed ID: 18337748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras.
    Ichimiya H; Maeda K; Enomoto A; Weng L; Takahashi M; Murohara T
    Biochem Biophys Res Commun; 2015 May; 461(2):260-7. PubMed ID: 25869066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells.
    Noda K; Zhang J; Fukuhara S; Kunimoto S; Yoshimura M; Mochizuki N
    Mol Biol Cell; 2010 Feb; 21(4):584-96. PubMed ID: 20032304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    J Physiol; 2004 Jan; 554(Pt 1):78-88. PubMed ID: 14678493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VE-cadherin interacts with cell polarity protein Pals1 to regulate vascular lumen formation.
    Brinkmann BF; Steinbacher T; Hartmann C; Kummer D; Pajonczyk D; Mirzapourshafiyi F; Nakayama M; Weide T; Gerke V; Ebnet K
    Mol Biol Cell; 2016 Sep; 27(18):2811-21. PubMed ID: 27466317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rab11a Mediates Vascular Endothelial-Cadherin Recycling and Controls Endothelial Barrier Function.
    Yan Z; Wang ZG; Segev N; Hu S; Minshall RD; Dull RO; Zhang M; Malik AB; Hu G
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):339-49. PubMed ID: 26663395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF.
    Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D
    J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase.
    Xu M; Waters CL; Hu C; Wysolmerski RB; Vincent PA; Minnear FL
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1309-18. PubMed ID: 17670896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.
    Fu P; Ramchandran R; Shaaya M; Huang L; Ebenezer DL; Jiang Y; Komarova Y; Vogel SM; Malik AB; Minshall RD; Du G; Tonks NK; Natarajan V
    J Biol Chem; 2020 May; 295(22):7669-7685. PubMed ID: 32327488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts.
    Almagro S; Durmort C; Chervin-Pétinot A; Heyraud S; Dubois M; Lambert O; Maillefaud C; Hewat E; Schaal JP; Huber P; Gulino-Debrac D
    Mol Cell Biol; 2010 Apr; 30(7):1703-17. PubMed ID: 20123970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.
    Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D
    EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells.
    Xiao K; Allison DF; Kottke MD; Summers S; Sorescu GP; Faundez V; Kowalczyk AP
    J Biol Chem; 2003 May; 278(21):19199-208. PubMed ID: 12626512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
    Achyuthan KE; Mary A; Greenberg CS
    J Biol Chem; 1988 Oct; 263(28):14296-301. PubMed ID: 2902081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear Magnetic Resonance Solution Structure of the Recombinant Fragment Containing Three Fibrin-Binding Cysteine-Rich Domains of the Very Low Density Lipoprotein Receptor.
    Banerjee K; Yakovlev S; Gruschus JM; Medved L; Tjandra N
    Biochemistry; 2018 Jul; 57(30):4395-4403. PubMed ID: 29965730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.